XML 14 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Consolidated Statements Of Operations    
Revenue
Expenses    
Research and development expenses $ 281,218 $ 975,667
General and administrative expenses 1,037,289 1,155,729
Total operating expenses 1,318,507 2,131,396
Net loss $ (1,318,507) $ (2,131,396)
Earnings per share    
Loss per common share $ (0.02) $ (0.03)
Weighted average shares outstanding 67,233,254 66,575,122